2004
DOI: 10.1016/j.jsbmb.2004.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: changes in nuclear and membranal binding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
17
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(21 citation statements)
references
References 13 publications
4
17
0
Order By: Relevance
“…Bone growth in diabetes which is disturbed [17,28] is also not enhanced to the same extent by hormone replacement therapy [26] and might be the result of lower hip BMD in young women due to their type 1 diabetes [27]; therefore the use of the specific phytoestrogens and their synthetic derivatives that we use in this study, might provide an alternative solution. Further studies in this direction in animal models have to be conducted for this purpose.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Bone growth in diabetes which is disturbed [17,28] is also not enhanced to the same extent by hormone replacement therapy [26] and might be the result of lower hip BMD in young women due to their type 1 diabetes [27]; therefore the use of the specific phytoestrogens and their synthetic derivatives that we use in this study, might provide an alternative solution. Further studies in this direction in animal models have to be conducted for this purpose.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, cells were incubated for 90min at 4°C with either of the steroid protein conjugates (estradiol 6-carboxymethyl-oxime; E 2 -6-CMO-ovalbumin [26][27][28][29], 10µM/well, E 2 -Ov conjugate labeled with Europium (1:1000, 200µl in binding medium) were then added and the incubation was continued for another 60 minutes at 4°C. Binding was terminated by four successive washes with ice-cold binding medium.…”
Section: Competitive Binding Assay For Membrane Estrogen Binding Actimentioning
confidence: 99%
See 1 more Smart Citation
“…Cell cultures: (a) Primary human bone cells (Obs) from females or males were prepared by us [9]. (b) Human bone cell lines: SaOS2-and hFOB-human bone cell lines were obtained from ATCC (Manassas, VA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Adequate availability of vitamin D 3 and its active metabolite, 1,25 is essential for skeletal health and modulation of cell growth and differentiation of both Obs and osteoclasts [4], but it is hypercalcemic [4,5] and therefore optimal bone growth and prevention of osteoporosis which requires its adequate concentrations [6,7] needs the use of its less-calcemic analogs having no adverse calcemic activity. We tested structurally modified less-calcemic analogs for their activity and found that JKF1624F 2 -2(JKF) and QW1624F 2 -2(QW) [8,9] stimulated Obs [8,9] and pre-treatment with them up-regulated both responsiveness and sensitivity to estrogens [8][9][10]. In the present study we analyzed the expression and regulation of LOs as well as ROS formation by these analogs.…”
Section: Introductionmentioning
confidence: 92%